Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis.
Fargnoli MC, Esposito M, Ferrucci S, Girolomoni G, Offidani A, Patrizi A, Peris K, Costanzo A, Malara G, Pellacani G, Romanelli M, Amerio P, Cristaudo A, Flori ML, Motolese A, Betto P, Patruno C, Pigatto P, Sirna R, Stinco G, Zalaudek I, Bianchi L, Boccaletti V, Cannavò SP, Cusano F, Lembo S, Mozzillo R, Gallo R, Potenza C, Rongioletti F, Tiberio R, Grieco T, Micali G, Persechino S, Pettinato M, Pucci S, Savi E, Stingeni L, Romano A, Argenziano G; Dupilumab Italian National Access Program (Dup-INAP group). Fargnoli MC, et al. Among authors: amerio p. J Dermatolog Treat. 2021 Aug;32(5):507-513. doi: 10.1080/09546634.2019.1682503. Epub 2019 Oct 28. J Dermatolog Treat. 2021. PMID: 31647347 Free article.
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis.
Fargnoli MC, Esposito M, Ferrucci S, Girolomoni G, Offidani A, Patrizi A, Peris K, Costanzo A, Malara G, Pellacani G, Romanelli M, Amerio P, Cristaudo A, Flori ML, Motolese A, Betto P, Patruno C, Pigatto P, Peccianti C, Stinco G, Zalaudek I, Bianchi L, Boccaletti V, Cannavo SP, Cusano F, Lembo S, Mozzillo R, Gallo R, Potenza C, Rongioletti F, Tiberio R, Grieco T, Micali G, Persechino S, Pettinato M, Pucci S, Stingeni L, Caruso C, Argenziano G; Dupilumab Italian National Access Program (Dup-INAP Group).. Fargnoli MC, et al. Among authors: amerio p. J Dermatolog Treat. 2022 Mar;33(2):1146-1149. doi: 10.1080/09546634.2020.1773379. Epub 2020 Jul 3. J Dermatolog Treat. 2022. PMID: 32436765 Free article. No abstract available.
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study.
Patruno C, Napolitano M, Argenziano G, Peris K, Ortoncelli M, Girolomoni G, Offidani A, Ferrucci SM, Amoruso GF, Rossi M, Stingeni L, Malara G, Grieco T, Foti C, Gattoni M, Loi C, Iannone M, Talamonti M, Stinco G, Rongioletti F, Pigatto PD, Cristaudo A, Nettis E, Corazza M, Guarneri F, Amerio P, Esposito M, Belloni Fortina A, Potenza C, Fabbrocini G; DADE - Dupilumab for Atopic Dermatitis of the Elderly study group. Patruno C, et al. Among authors: amerio p. J Eur Acad Dermatol Venereol. 2021 Apr;35(4):958-964. doi: 10.1111/jdv.17094. Epub 2021 Jan 19. J Eur Acad Dermatol Venereol. 2021. PMID: 33332697
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study.
Campanati A, Bianchelli T, Gesuita R, Foti C, Malara G, Micali G, Amerio P, Rongioletti F, Corazza M, Patrizi A, Peris K, Pimpinelli N, Parodi A, Fargnoli MC, Cannavo SP, Pigatto P, Pellacani G, Ferrucci SM, Argenziano G, Cusano F, Fabbrocini G, Stingeni L, Potenza MC, Romanelli M, Bianchi L, Offidani A; and collaborators. Campanati A, et al. Among authors: amerio p. Arch Dermatol Res. 2022 Aug;314(6):593-603. doi: 10.1007/s00403-021-02243-w. Epub 2021 Jun 7. Arch Dermatol Res. 2022. PMID: 34100126 Free PMC article.
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience.
Conti A, Peccerillo F, Amerio P, Balato A, Bardazzi F, Bianchi L, Burlando M, Cannavò SP, Chiricozzi A, Dapavo P, De Simone C, Fargnoli MC, Gambardella A, Gisondi P, Malagoli P, Malara G, Mugheddu C, Offidani AM, Piaserico S, Prignano F, Stingeni L, Pellacani G. Conti A, et al. Among authors: amerio p. Br J Dermatol. 2019 Jun;180(6):1547-1548. doi: 10.1111/bjd.17580. Epub 2019 Feb 21. Br J Dermatol. 2019. PMID: 30578668 No abstract available.
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.
Peris K, Lo Schiavo A, Fabbrocini G, Dini V, Patrizi A, Fusano M, Bianchi L, Guanziroli E, Guarneri C, Parodi A, Bertoldi A, Musumeci ML, Offidani A, Rongioletti F, Pistone G, Malara G, Potenza C, Casari A, Franchi C, Ardigò M, Cusano F, Stingeni L, Amerio P, Mancini LL, Prignano F, Deboli T, Gualberti G, Saragaglia V, Bettoli V. Peris K, et al. Among authors: amerio p. J Eur Acad Dermatol Venereol. 2019 Apr;33(4):766-773. doi: 10.1111/jdv.15425. Epub 2019 Mar 5. J Eur Acad Dermatol Venereol. 2019. PMID: 30633405 Free PMC article.
A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic.
Hansel K, Zangrilli A, Bianchi L, Peris K, Chiricozzi A, Offidani A, Diotallevi F, Fargnoli MC, Esposito M, Amerio P, Gualdi G, Bianchi L, Stingeni L. Hansel K, et al. Among authors: amerio p. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e169-e170. doi: 10.1111/jdv.17003. Epub 2020 Nov 8. J Eur Acad Dermatol Venereol. 2021. PMID: 33080112 No abstract available.
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study.
Campanati A, Bianchelli T, Gesuita R, Foti C, Malara G, Micali G, Amerio P, Rongioletti F, Corazza M, Patrizi A, Peris K, Pimpinelli N, Parodi A, Fargnoli MC, Cannavo SP, Pigatto P, Pellacani G, Ferrucci SM, Argenziano G, Cusano F, Fabbrocini G, Stingeni L, Potenza MC, Romanelli M, Bianchi L, Offidani A; and collaborators. Campanati A, et al. Among authors: amerio p. Arch Dermatol Res. 2022 Aug;314(6):605-607. doi: 10.1007/s00403-021-02266-3. Arch Dermatol Res. 2022. PMID: 34235586 No abstract available.
A 52-week update of a multicentre real-life experience on effectiveness and safety of risankizumab in psoriasis.
Hansel K, Zangrilli A, Bianchi L, Peris K, Chiricozzi A, Offidani A, Diotallevi F, Fargnoli MC, Esposito M, Amerio P, Gualdi G, Bianchi L, Stingeni L. Hansel K, et al. Among authors: amerio p. J Eur Acad Dermatol Venereol. 2022 Feb;36(2):e111-e113. doi: 10.1111/jdv.17656. Epub 2021 Sep 19. J Eur Acad Dermatol Venereol. 2022. PMID: 34510556 No abstract available.
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy.
Talamonti M, Galluzzo M, Chiricozzi A, Quaglino P, Fabbrocini G, Gisondi P, Marzano AV, Potenza C, Conti A, Parodi A, Belloni Fortina A, Bardazzi F, Argenziano G, Rongioletti F, Stingeni L, Micali G, Loconsole F, Venturini M, Bongiorno MR, Feliciani C, Rubegni P, Amerio P, Fargnoli MC, Pigatto P, Savoia P, Nisticò SP, Giustini S, Carugno A, Cannavò SP, Rech G, Prignano F, Offidani A, Lombardo M, Zalaudek I, Bianchi L, Peris K; PSO-BIO-COVID study group. Talamonti M, et al. Among authors: amerio p. J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e770-e772. doi: 10.1111/jdv.16841. Epub 2020 Aug 10. J Eur Acad Dermatol Venereol. 2020. PMID: 32735716 Free PMC article. No abstract available.
285 results